Search clinical trials for: Abiraterone with Prednisone or Enzalutamide
Total 1172 results
-
Kangpu Biopharmaceuticals, Ltd.CompletedCastration-Resistant Prostate CancerUnited States
-
Curium US LLCActive, not recruitingMetastasis From Malignant Tumor of ProstateUnited States, France, Spain, Italy
-
Royal Marsden NHS Foundation TrustUniversity College, London; The Leeds Teaching Hospitals NHS Trust; Belfast Health... and other collaboratorsUnknownProstate Cancer | Metastasis | Toxicity Due to Radiotherapy | Circulating Tumour DNAUnited Kingdom
-
AstraZenecaParexelCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States, Australia, Spain, United Kingdom, Denmark, Belgium, Slovakia, Finland, Italy, France, Sweden
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Castration Resistant Prostate CancerChina
-
Medical University of South CarolinaNational Cancer Institute (NCI)Active, not recruiting
-
University Health Network, TorontoCompletedCastration-resistant Prostate CancerCanada
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
Jodi Layton, MDEMD SeronoTerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
Janssen Research & Development, LLCNo longer available
-
Cedars-Sinai Medical CenterCompletedProstate CancerUnited States
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
Veru Inc.TerminatedMetastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic CancerUnited States
-
ESSA PharmaceuticalsRecruitingProstate CancerCanada, United States, Australia
-
GlaxoSmithKlineWithdrawn
-
GlaxoSmithKlineTerminatedSolid TumoursUnited States, Spain, Australia, United Kingdom
-
Epizyme, Inc.Active, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, Belgium
-
CelgeneCompletedSarcoidosis, PulmonaryUnited States, United Kingdom, Netherlands
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Jiangnan UniversityAffiliated Hospital of Jiangnan UniversityRecruitingCastration-resistant Prostate CancerChina
-
Astellas Pharma Global Development, Inc.PfizerRecruitingProstate CancerUnited States, Korea, Republic of, Japan, Belgium, Spain, Argentina, Australia, Canada, Chile, Czechia, Denmark, Finland, France, Georgia, Germany, Israel, Italy, Moldova, Republic of, New Zealand, Poland, Russian Federation, Slov... and more
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States
-
Cougar Biotechnology, Inc.CompletedProstatic NeoplasmsUnited States, Australia, France, United Kingdom, Belgium, Germany, Spain, Canada, Austria, Netherlands, Ireland, Hungary
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
PfizerAstellas Pharma IncActive, not recruiting
-
Nanjing University School of MedicineCompleted
-
University of HawaiiTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteDendreonRecruitingProstate Cancer | Metastatic Prostate CancerUnited States
-
The Netherlands Cancer InstituteCompletedMetastasis | Prostate Cancer MetastaticNetherlands
-
PfizerAstellas Pharma IncActive, not recruitingProstatic NeoplasmsUnited States
-
National Cancer Institute (NCI)Active, not recruitingCastrate Sensitive Prostate CancerUnited States
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
Janssen Research & Development, LLCTerminatedProstatic NeoplasmsUnited States, Canada
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
University of SydneyCanadian Cancer Trials Group; Australian and New Zealand Urogenital and Prostate... and other collaboratorsActive, not recruitingProstatic NeoplasmsNew Zealand, Canada, United States, Australia, United Kingdom, Ireland
-
Universität des SaarlandesCompleted
-
University of Michigan Rogel Cancer CenterCompletedProstate CancerUnited States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
Janssen Research & Development, LLCApproved for marketingMetastatic Castration-resistant Prostate CancerBrazil, Austria, Estonia, Israel, Mexico
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Hoffmann-La RocheActive, not recruitingMetastatic Prostate CancerUnited States, Belgium, France, United Kingdom, Canada, Korea, Republic of, China, Denmark, Greece, Ireland, Portugal, Spain, Italy, Brazil, Mexico, Australia, Thailand, Japan, Costa Rica, Israel, Russian Federation, Austria, Hungary, Norwa... and more
-
West China HospitalNot yet recruitingProstatic Neoplasms, Castration-Resistant | Drug Therapy, CombinationChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHigh-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more